CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
Scope & Guideline
Innovative Insights into Eukaryotic Genetics
Introduction
Aims and Scopes
- Gene Regulation Mechanisms:
The journal focuses on the diverse mechanisms that regulate gene expression, including epigenetic modifications, transcriptional control, and post-transcriptional modifications like RNA splicing and degradation. - Cancer Biology and Therapeutics:
A significant portion of the published research addresses the role of gene expression in cancer biology, exploring how alterations in gene regulation contribute to tumorigenesis, metastasis, and therapeutic resistance. - Molecular Pathways and Signaling:
Research articles frequently investigate specific signaling pathways and their role in modulating gene expression, particularly in the context of various diseases, including cancer and neurodegenerative disorders. - Comparative Genomics and Transcriptomics:
The journal also highlights studies that employ comparative genomics and transcriptomic analyses to understand gene expression patterns across different species or cancer types, providing insights into evolutionary biology and disease mechanisms. - Stem Cells and Regenerative Medicine:
Another area of focus is the role of gene expression in stem cell biology and regenerative medicine, exploring how gene regulation affects stem cell differentiation and therapeutic applications.
Trending and Emerging
- Cancer Immunotherapy and Gene Expression:
Recent publications show a growing interest in the relationship between gene expression profiles and cancer immunotherapy outcomes, highlighting the importance of understanding immune evasion mechanisms and potential biomarkers for therapy response. - Single-Cell Transcriptomics:
There is an increasing emphasis on single-cell transcriptomic studies, which allow for a more nuanced understanding of gene expression heterogeneity within tumors and other tissues, providing insights into cellular dynamics and disease progression. - Multi-Omics Approaches:
The integration of various omics data (genomics, transcriptomics, proteomics) is becoming a prominent theme, reflecting a trend towards comprehensive analyses that provide a holistic view of gene regulation and its impact on health and disease. - Role of Epigenetics in Disease:
The exploration of epigenetic modifications and their influence on gene expression is gaining more attention, particularly in the context of cancer and chronic diseases, indicating a shift towards understanding the complex regulatory networks governing gene activity. - Therapeutic Applications of Gene Editing:
Emerging research is increasingly focusing on gene editing technologies, such as CRISPR, and their potential therapeutic applications in treating genetic disorders and cancers, reflecting a significant trend towards translational research.
Declining or Waning
- Non-Coding RNA Studies:
Although non-coding RNAs, including microRNAs and long non-coding RNAs, were once a major focus, the frequency of papers specifically examining their roles in gene regulation has decreased, suggesting a shift towards more mechanistic and pathway-oriented studies. - Basic Research on Gene Expression Techniques:
There appears to be a declining interest in publishing foundational research on traditional gene expression techniques and methodologies, as the field moves towards more integrative and systems biology approaches. - Environmental Influences on Gene Expression:
Research exploring the impact of environmental factors on gene expression, while still relevant, has seen fewer dedicated studies, indicating a possible shift towards more direct investigations of genetic and epigenetic mechanisms.
Similar Journals
Advances in Cancer Biology-Metastasis
Advancing Understanding, Transforming Outcomes.Advances in Cancer Biology-Metastasis is an emerging journal published by Elsevier, aimed at advancing our understanding of the complexities of cancer biology, with a specific focus on the mechanisms and pathways related to metastasis. With an E-ISSN of 2667-3940, this journal offers a platform for researchers, professionals, and students in the fields of Cancer Research and Cell Biology to disseminate innovative findings and discuss novel therapeutic approaches. Though currently classified in the Q4 quartile across both Cancer Research and Cell Biology categories, the journal aspires to enhance its impact through rigorous peer review and high-quality publication. Positioned to cover the years from 2021 to 2024, it seeks to bridge gaps in foundational knowledge and promote collaborative research efforts that could pivot the current understanding of cancer metastasis. Researchers are encouraged to take advantage of this platform to advocate for advancements in cancer biology, making significant contributions that can influence both academic and clinical practices.
Transcription-Austin
Elevating Research in Transcriptional ProcessesTranscription-Austin is a leading academic journal published by Taylor & Francis Inc., dedicated to the rapidly evolving fields of biochemistry, biotechnology, and genetics. As a testament to its significance in the academic community, it has been ranked in the Q1 category across all three fields, establishing itself as a premier platform for high-quality research and innovative findings since its inception in 2010. With an H-index reflecting robust academic influence, Transcription-Austin invites contributions that enhance our understanding of transcriptional processes and their implications in various biological contexts. Researchers and professionals alike will find value in its rigorous peer-reviewed articles, which set the stage for future advancements in molecular biology. The journal is based in the United Kingdom and provides a critical resource for scholars aiming to disseminate cutting-edge research to a global audience.
BIOLOGICAL PROCEDURES ONLINE
Fostering Collaboration in the Evolving World of Biology.BIOLOGICAL PROCEDURES ONLINE is a premier open-access journal published by BMC, dedicated to advancing the fields of biochemistry, genetics, and molecular biology. With its electronic ISSN 1480-9222 and a strong commitment to accessibility since 2009, this journal provides a vital platform for researchers and scholars to disseminate their findings and foster collaboration within the scientific community. Based in the United Kingdom, this journal has garnered an impressive reputation, achieving Q1 status in the 2023 category rankings, with notable inclusion in the Scopus rankings, placing it in the 86th percentile among 221 peer journals in the general biochemistry, genetics, and molecular biology domain. It covers a broad range of topics, ensuring coverage of the latest advancements and methodologies in biological procedures, making it an essential resource for academics, practitioners, and students alike. Researchers are encouraged to submit their innovative work and contribute to the ongoing dialogue in this dynamic and ever-evolving field.
JOURNAL OF GENE MEDICINE
Elevating Standards in Gene Medicine ResearchThe Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.
Journal of Genetics and Genomics
Advancing Knowledge in Genetics and GenomicsThe Journal of Genetics and Genomics, published by SCIENCE PRESS in China, stands as a significant contributor to the fields of Genetics and Molecular Biology. With an ISSN of 1673-8527 and E-ISSN 1873-5533, this esteemed journal has achieved a remarkable reputation, holding a prestigious Q1 ranking in both Genetics and Molecular Biology as of 2023. This journal not only showcases pioneering research but also fosters vital discussions on contemporary challenges and innovations within genomic sciences. As part of its commitment to facilitating scientific advancement, the journal encompasses a range of research articles, reviews, and short communications, all aiming to illuminate the complexities of genetic structures and functions from 2007 to 2024. Researchers, professionals, and students alike are encouraged to engage with its content, which ranks favorably in Scopus—placing it within the top tier of its categories. Join the community of academic excellence and explore the latest findings that shape our understanding of genomics.
GENOME
Illuminating Pathways in Genetic ResearchGENOME is a leading peer-reviewed journal published by Canadian Science Publishing, dedicated to advancing the field of genetics, biotechnology, and molecular biology. With a strong commitment to disseminating high-quality research, GENOME has earned a reputable spot in the academic community, boasting a Q2 classification in Biotechnology and Medicine (miscellaneous), and a Q3 rank in Genetics and Molecular Biology for 2023. The journal, identified by its ISSN 0831-2796 and E-ISSN 1480-3321, publishes innovative studies that span from 1987 to 2024, ensuring a rich historical context while addressing contemporary challenges in the field. Researchers and professionals are encouraged to contribute and engage with content that shapes the landscape of genetic research. Although the journal does not currently provide open access, it remains a vital resource for those committed to the exploration of genomic sciences, making it an essential read for both seasoned researchers and students alike.
GENES & DEVELOPMENT
Empowering Researchers with Cutting-Edge Genetic DiscoveriesGENES & DEVELOPMENT, published by COLD SPRING HARBOR LAB PRESS, stands as a premier journal in the fields of Developmental Biology and Genetics, boasting a remarkable impact factor that reflects its prestigious position in the academic community—ranking Q1 in both disciplines as of 2023. Since its inception in 1987, this journal has been at the forefront of disseminating cutting-edge research, effectively bridging the gap between laboratory breakthroughs and their applications in health and disease. Researchers and professionals rely on GENES & DEVELOPMENT for its rigorous peer-review process and its commitment to promoting innovative studies that unravel the complexities of gene functions and developmental processes. With Scopus rankings placing it in the top percentile among its peers, this journal serves as a vital resource for students and established scientists alike, aspiring to expand their knowledge and contribute to the ever-evolving landscape of genetic and developmental research.
Molecular Cell
Where Innovative Research Meets Cellular Insight.Molecular Cell, published by Cell Press, is a leading journal in the fields of cell biology and molecular biology. Established in 1997, this prestigious journal boasts a significant impact within the scientific community, evidenced by its impressive 2023 Scopus rankings, placing it in the top 2% of its field (Rank #10/410 in Molecular Biology, Rank #12/285 in Cell Biology). With a focus on cutting-edge research that bridges the gap between molecular genetics and cellular function, Molecular Cell serves as an essential platform for the dissemination of vital findings and innovative methodologies. Although it follows a traditional publishing model without Open Access options, its rigorous peer-review process and high standards ensure that articles published within these pages are of the utmost quality, making it an invaluable resource for researchers, professionals, and students alike seeking to stay at the forefront of scientific discovery. The journal's address is 50 Hampshire St, Floor 5, Cambridge, MA 02139, United States, reinforcing its commitment to fostering scientific excellence and collaboration.
MOLECULAR GENETICS AND GENOMICS
Advancing the Frontiers of Genetic ResearchMOLECULAR GENETICS AND GENOMICS is a distinguished journal published by SPRINGER HEIDELBERG that serves as a pivotal platform for the communication of cutting-edge research and developments in the fields of genetics, molecular biology, and medicine. With an ISSN of 1617-4615 and an E-ISSN of 1617-4623, this journal has established itself since its inception in 1994 as a significant resource for researchers aiming to explore the complexities of genetic interactions and their implications in various biological systems. The journal is indexed in Scopus, with respectable rankings in the Genetics, Molecular Biology, and Biochemistry categories, showcasing its position within the academic community. It is categorized in the 2023 rankings as Q3 in Genetics, Q2 in Medicine (miscellaneous), and Q3 in Molecular Biology, indicating its relevance and quality in the scientific discourse. The journal also promotes open access, ensuring that researchers and professionals can easily share and advance knowledge in the rapidly evolving disciplines of molecular genetics and genomics. As the journal continues to bridge the gap between experimental and theoretical research, it presents a vital space for innovation, fostering collaborations and scholarly exchange among its readership.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Connecting researchers with breakthrough insights.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH is a premier journal published by Elsevier, dedicated to advancing the fields of cell biology and molecular biology. Established in 1982, this influential journal has been at the forefront of scientific research and innovation, currently holding esteemed positions with a Q2 ranking in Cell Biology and a Q1 ranking in Molecular Biology for 2023, reflecting its commitment to high-quality scholarship. With an impressive impact factor, it ranks in the 82nd and 78th percentiles for Molecular Biology and Cell Biology, respectively, amongst its peers. Researchers, professionals, and students will find this journal to be an invaluable resource for exploring the latest discoveries and methodologies in the molecular mechanisms underlying cellular functions. Although it is not an open-access journal, the insights offered in its pages contribute significantly to the scientific community's understanding of cellular and molecular processes, ensuring it remains a vital platform for disseminating cutting-edge research.